(CNN) — Elizabeth Holmes won’t be starting her 11-year prison sentence just yet.

The disgraced Theranos founder was previously expected to report to prison on Thursday, but she will remain free a little longer while the court considers a last-minute appeal, according to a filing Tuesday night.

Holmes was sentenced last November after she was convicted months earlier on multiple charges of defrauding investors while running the now-defunct blood testing startup. Earlier this month, her request to remain free while she appeals her conviction was denied by a judge, setting her up to report to prison on April 27.

On Tuesday, however, Holmes’ legal team filed an appeal of the judge’s decision. As a result, Holmes can remain free on bail while the latest appeal is considered by the court, as per the court’s rules.

Holmes dropped out of Stanford at the age of 19 to focus full-time on Theranos, the health tech startup which claimed to have invented technology that could accurately test for a range of conditions using just a few drops of blood. Theranos raised $945 million from an impressive list of investors and was valued at some $9 billion at its peak — making Holmes a paper billionaire.

Her company began to unravel after a Wall Street Journal investigation in 2015 reported that Theranos had only ever performed roughly a dozen of the hundreds of tests it offered using its proprietary technology, and with questionable accuracy. It also came to light that Theranos was relying on third-party manufactured devices from traditional blood testing companies rather than its own technology.

Holmes’ ex-boyfriend and former COO Ramesh “Sunny” Balwani was indicted alongside Holmes and convicted of fraud in a separate trial. Like Holmes, Balwani’s legal team delayed the start of his prison sentence by roughly a month with an appeal.

Balwani reported to prison last week to serve out his nearly 13-year sentence.

(Copyright (c) 2024 CNN. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)

Join our Newsletter for the latest news right to your inbox